APA Alıntı

Singh, D., Criner, G. J., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Lange, P., . . . Lomas, D. (2021). InforMing the PAthway of COPD Treatment (IMPACT) trial: Fibrinogen levels predict risk of moderate or severe exacerbations. Respir Res.

Chicago Stili Alıntı

Singh, Dave, et al. "InforMing the PAthway of COPD Treatment (IMPACT) Trial: Fibrinogen Levels Predict Risk of Moderate or Severe Exacerbations." Respir Res 2021.

MLA Alıntı

Singh, Dave, et al. "InforMing the PAthway of COPD Treatment (IMPACT) Trial: Fibrinogen Levels Predict Risk of Moderate or Severe Exacerbations." Respir Res 2021.